Sort
21,453 grants matching “tuberculosis”
Tuberculosis Elimination and Laboratory Cooperative Agreement- Vermont Department of Health
$160,195Patsy Tassler Kelso · Vermont State Agency Of Human Services · U52 · FY2015 · PS
PATHOGENESIS OF INFECTIOUS DISEASES TRAINING PROGRAM
$160,137Weill Medical College Of Cornell Univ · T32 · FY2000 · AI
Crystallographic Studies of Polyphosphate Kinase
$160,070University Of Washington · R01 · FY2003 · AI
UCB/UCSF AIDS International Training and Research Program (AITRP)
$160,000Arthur L. Reingold · University Of California Berkeley · D43 · FY2013 · TW
Identifying the Human Targets of Secreted M. tuberculosis Effectors by Proteomics
$159,988Bennett Penn · University Of California, San Francisco · K08 · FY2015 · AI
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia
$159,695Frederick Lewis Altice · Yale University · R21 · FY2021 · DA
The role of IL-2 in promoting CD8 memory T cell responsiveness
$159,680Matthew A Williams · University Of Utah · K22 · FY2007 · AI
Impact of Effective Chemotherapy on Transmission of Drug Resistant Tuberculosis
$159,652Martha Louiza Van Der Walt · Medical Research Council Of South Africa · R01 · FY2012 · AI
MYCOBACTERIUM TUBERCULOSIS ALKYLHYDROPEROXIDASE
$159,403University Of California San Francisco · P01 · FY2001 · GM
COMPUTATION
$159,403University Of California San Francisco · P01 · FY2001 · GM
Mycobacterium tuberculosis aerobiology and novel tools to assess infectiousness
$159,399David J. Horne · University Of Washington · UH2 · FY2022 · AI
Pharmacology Core
$159,254Francesca T. Aweeka · University Of California, San Francisco · P30 · FY2008 · AI
CAP: Development of a Tuberculosis-Specific PET Imaging Agent
$159,242Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Inflammation, Aging, Microbes, Obstructive Lung Disease, and Diffusion Abnormalities (I AM OLD-DA): Pulmonary function in females, evaluating the menopausal transition and immune activation (pFEMI).
$159,182Laurence Huang · University Of California, San Francisco · R01 · FY2022 · HL
Replisome dynamics in M tuberculosis_linking persistence to genetic resistance
$159,119Digby Francis Warner · University Of Cape Town · U01 · FY2015 · HD
RHESUS MACAQUE MODEL OF TUBERCULOSIS
$159,000Oregon Health And Science University · R21 · FY2001 · RR
Mechanism of retinoic acid receptor induced innate immune responses
$158,987Philip T. Liu · University Of California Los Angeles · K22 · FY2010 · AI
UCSF-UCB TRAC Clinical Sciences Core
$158,872Priya B. Shete · University Of California, San Francisco · P30 · FY2025 · AI
Basic Science Core - Biosafety & Biocontainment Core (BBC)
$158,822Jordi B Torrelles · Texas Biomedical Research Institute · P30 · FY2025 · AI
A Solid-State Nanopore Biosensor for Rapid Detection of Mycobacterium tuberculosis Antigens in Pediatric Blood Samples
$158,800Chang Liu · University Of South Carolina At Columbia · K22 · FY2019 · AI
Structural Topology of a Small Multidrug Resistant Efflux Pump
$158,800Nathaniel J. Traaseth · New York University · K22 · FY2011 · AI
Pharmacology
$158,792Francesca T. Aweeka · University Of California, San Francisco · P30 · FY2012 · AI
Emory-CDC CTU
$158,784Colleen F Kelley · Emory University · UM1 · FY2025 · AI
Clinical Core
$158,760Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2022 · AI
Improved Tools for Nontuberculous Mycobacteria Lung Disease
$158,670Keira Alexis Cohen · Johns Hopkins University · K08 · FY2020 · HL